Ekso Bionics Holdings, Inc.
EKSO
$0.4599
$0.055313.67%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -6.19% | 38.42% | 42.88% | 21.87% | -1.13% |
| Total Depreciation and Amortization | -7.87% | -4.01% | -7.24% | -1.93% | 67.44% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 466.90% | -115.86% | -16.47% | 55.66% | 178.45% |
| Change in Net Operating Assets | -103.06% | 64.55% | -376.86% | -68.20% | 354.60% |
| Cash from Operations | 9.53% | 32.09% | 8.03% | 17.75% | 56.53% |
| Capital Expenditure | 51.16% | 52.94% | 100.00% | 80.95% | 18.87% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 51.16% | 52.94% | 100.00% | 80.95% | 99.15% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 0.32% | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -190.23% | -- | -- | -- | -- |
| Foreign Exchange rate Adjustments | -55.00% | -- | 275.00% | -375.00% | -186.96% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -38.49% | 171.42% | 1.89% | 103.79% | 84.99% |
